Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Network... · 21:12 · 1.472 diputar

Dari album JAMA Neurology Author Interviews

Deskripsi

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

More By JAMA Network...

1
AlbumJAMA Neurology Author Interviews
JAMA Network... · 3.974 diputar
2
Acoustic Analysis of Primary Care Patient–Clinician Conversations to Screen for Cognitive Impairment
JAMA Network... · 5.214 diputar · 22:39
3
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
JAMA Network... · 2.912 diputar · 14:18
4
Epstein-Barr Virus Antibodies and Multiple Sclerosis
JAMA Network... · 3.170 diputar · 14:58
5
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage
JAMA Network... · 1.962 diputar · 15:56
6
US Burden of Disorders Affecting the Nervous System
JAMA Network... · 3.746 diputar · 23:32
7
Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease
JAMA Network... · 3.987 diputar · 19:27
8
Phenoconversion in Pure Autonomic Failure
JAMA Network... · 1.092 diputar · 24:00
9
Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events
JAMA Network... · 1.954 diputar · 19:31
10
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
JAMA Network... · 2.983 diputar · 22:32

Mungkin Kamu Suka